Ahmad Abuhelwa, MD

home / authors / ahmad-abuhelwa-md

Ahmad Abuhelwa, MD, is an assistant professor of clinical pharmacology and pharmacometrics at the University of Sharjah, United Arab Emirates.

Articles

Statins: Unexpected Allies in Cancer? Promising New Research in CLL

Ahmad Abuhelwa, MD

May 4th 2025

Ahmad Abuhelwa, MD, discusses the significance of a study exploring statin use in patients with chronic lymphocytic leukemia.

CLL/SLL Treatment: Could Statins Play a Protective Role?

Ahmad Abuhelwa, MD

May 2nd 2025

Ahmad Abuhelwa, MD, discusses an analysis exploring the connection between statins and better outcomes in patients with CLL and SLL.

CLL & Statins: A Surprising Link

Ahmad Abuhelwa, MD

May 1st 2025

Ahmad Abuhelwa, MD, discusses the mechanisms of statins and how they can play a surprisingly beneficial role in patients with chronic lymphocytic leukemia.

Latest Updated Articles

Published: December 3rd 2024 | Updated: December 6th 2024

ASH 2024 Preview for Community Oncologists: The Show and After Show

Published: May 6th 2024 | Updated: May 21st 2024

FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors

Published: April 28th 2025 | Updated: May 18th 2025

Starting Therapy for Intermediate-Risk Myelofibrosis Based on Hemoglobin

Published: April 24th 2025 | Updated: May 18th 2025

Optimizing CAR T-Cell Therapy Prep in Multiple Myeloma After Relapse

Published: April 15th 2025 | Updated: May 18th 2025

Participants Explain Rationale for Different IO/TKI Options for ccRCC

Published: August 10th 2021 | Updated: May 18th 2025

FDA Accepts sBLA for Pembrolizumab Monotherapy for Endometrial Cancer

Do Not Sell My Information

Privacy

Terms & Conditions

Editorial Board

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777